Answers are grounded in this paper and cite their sources.
We observed a rebound in consumption of antibacterials for systemic use (ATC J01) in the community sector in the European Union/European Economic Area during 2021 and 2022, after an observed decrease between 2019 and 2020. The rates in 2022 returned to pre-COVID-19-pandemic levels and were exceeded in 13 countries. Although these patterns could partly be a result of changes in disease transmission during the study period, it could also reflect a lost opportunity to strengthen and reinforce prudent antibiotic use.
No takes yet. Share an insight, caveat, or question.
Ventura-Gabarró et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: